Turning off inflammation inhibits autoimmune myocarditis: MiRNA-15a/16 inhibits cardiac inflammation and injury via down regulation of its target gene, 17/March/2015, 15.27

Natural product-based Life-span extension therapy: Mef2 inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 17/March/2014, 15.20
March 17, 2015
Vitamin-based therapy for pulmonary hypertension: Cholecalciferol stifles pulmonary hypertension via down regulation of its target gene, 17/March/2015, 15.34
March 17, 2015
Show all

A recent study from the Department of Cardiology and Pneumology, Charité University Medicine Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin 12200, Germany shows that “Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury.” This study was published in the 1 August’13 issue of the Journal “Cardiovascular Research” by Prof. Skurk C., Dr. Jenke A and others.

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Turning off inflammation inhibits autoimmune myocarditis: MiRNA-15a/16 inhibits cardiac inflammation and injury via down regulation of its target gene. Thus, pharmacological formulations encompassing “MiRNA-15a/16 activators” may be used to treat patients suffering from autoimmune myocarditis.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,  Turning off inflammation inhibits autoimmune myocarditis: MiRNA-15a/16 inhibits cardiac inflammation and injury via down regulation of its target gene, 17/March/2015,  15.27,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Undisclosed information: How MiRNA-15a/16 suppresses  cardiac inflammation and injury

* Research cooperation

Comments are closed.